Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer. (Record no. 26084512)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02187 a2200685 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517100432.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201702s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2374-2445 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1001/jamaoncol.2016.1197 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Powles, Thomas |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20170221 |
| 245 00 - TITLE STATEMENT | |
| Title | Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | JAMA oncology |
| Date of publication, distribution, etc. | Oct 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1303-1309 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Angiogenesis Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Renal Cell |
| General subdivision | mortality |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemotherapy, Adjuvant |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytoreduction Surgical Procedures |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Indazoles |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kidney Neoplasms |
| General subdivision | mortality |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoadjuvant Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nephrectomy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proportional Hazards Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrimidines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfonamides |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sarwar, Naveed |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stockdale, Andrew |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sarker, Shah-Jalal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boleti, Ekaterini |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Protheroe, Andrew |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jones, Robert |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chowdhury, Simon |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peters, John |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Oades, Grenville |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Brien, Tim |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sullivan, Mark |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aitchison, Michael |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Beltran, Luis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Worth, Daniel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smith, Kate |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Michel, Constance |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Trevisan, Giorgia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Harvey-Jones, Elizabeth |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wimalasingham, Akhila |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sahdev, Anju |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ackerman, Charlotte |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Crabb, Simon |
| 773 0# - HOST ITEM ENTRY | |
| Title | JAMA oncology |
| Related parts | vol. 2 |
| -- | no. 10 |
| -- | p. 1303-1309 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1001/jamaoncol.2016.1197">https://doi.org/10.1001/jamaoncol.2016.1197</a> |
| Public note | Available from publisher's website |
No items available.